{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:25:44Z","timestamp":1785245144303,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC306\/2, GRK1743\/1, GRK1727\/2, KFO303\/1"],"award-info":[{"award-number":["EXC306\/2, GRK1743\/1, GRK1727\/2, KFO303\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01558","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T04:15:38Z","timestamp":1531368938000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase \u03b4 Inhibitor in Experimental Epidermolysis Bullosa Acquisita"],"prefix":"10.3389","volume":"9","author":[{"given":"Hiroshi","family":"Koga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Kasprick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Aul\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Godessart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Balagu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molmed.2013.06.003","article-title":"Emerging treatments for pemphigoid diseases","volume":"19","author":"Ludwig","year":"2013","journal-title":"Trends Mol Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.13446","article-title":"Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases","volume":"26","author":"Goletz","year":"2017","journal-title":"Exp Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris \u2013 incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2340\/00015555-1065","article-title":"Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases","volume":"91","author":"Kim","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"812029","DOI":"10.1155\/2013\/812029","article-title":"Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita","volume":"2013","author":"Ludwig","year":"2013","journal-title":"ISRN Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/JID.2015.356","article-title":"Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options","volume":"136","author":"Kasperkiewicz","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/exd.13415","article-title":"In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases","volume":"26","author":"Bieber","year":"2017","journal-title":"Exp Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.4049\/jimmunol.1300310","article-title":"B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita","volume":"191","author":"Iwata","year":"2013","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"J Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2015.00206","article-title":"Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment","volume":"23","author":"Hirose","year":"2016","journal-title":"Mol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/path.4023","article-title":"Genetic identification and functional validation of Fc\u03b3RIV as key molecule in autoantibody-induced tissue injury","volume":"228","author":"Kasperkiewicz","year":"2012","journal-title":"J Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.jid.2017.05.017","article-title":"The Syk tyrosine kinase is required for skin inflammation in an in vivo mouse model of epidermolysis bullosa acquisita","volume":"137","author":"N\u00e9meth","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1084\/jem.20132496","article-title":"The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment","volume":"211","author":"Kov\u00e1cs","year":"2014","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"ra23","DOI":"10.1126\/scisignal.2001617","article-title":"PI3K\u03b2 plays a critical role in neutrophil activation by immune complexes","volume":"4","author":"Kulkarni","year":"2011","journal-title":"Sci Signal"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/exd.13335","article-title":"Signaling and targeted-therapy of inflammatory cells in epidermolysis bullosa acquisita","volume":"26","author":"Ludwig","year":"2017","journal-title":"Exp Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fimmu.2012.00256","article-title":"Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies","volume":"3","author":"Puri","year":"2012","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ni0403-313","article-title":"The role of PI3K in immune cells","volume":"4","author":"Koyasu","year":"2003","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.4049\/jimmunol.0900432","article-title":"Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses","volume":"183","author":"Durand","year":"2009","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jaut.2012.04.001","article-title":"Attenuation of phosphoinositide 3-kinase \u03b4 signaling restrains autoimmune disease","volume":"38","author":"Maxwell","year":"2012","journal-title":"J Autoimmun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.4049\/jimmunol.170.5.2647","article-title":"Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement","volume":"170","author":"Sadhu","year":"2003","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0006-291X(03)01480-3","article-title":"Selective role of PI3K delta in neutrophil inflammatory responses","volume":"308","author":"Sadhu","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1182\/blood-2003-05-1667","article-title":"Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue","volume":"103","author":"Puri","year":"2004","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acsmedchemlett.6b00438","article-title":"Discovery of a potent, selective, and orally available PI3K\u03b4 inhibitor for the treatment of inflammatory diseases","volume":"8","author":"Erra","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.febslet.2011.04.071","article-title":"Insight into interactions of the von-Willebrand-factor-A-like domain 2 with the FNIII-like domain 9 of collagen VII by NMR and SPR","volume":"585","author":"Leineweber","year":"2011","journal-title":"FEBS Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.4049\/jimmunol.1501003","article-title":"Radiosensitive hematopoietic cells determine the extent of skin inflammation in experimental epidermolysis bullosa acquisita","volume":"195","author":"Iwata","year":"2015","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.toxlet.2012.08.020","article-title":"Multiparametric immunotoxicity screening in mice during early drug development","volume":"214","author":"Aul\u00ed","year":"2012","journal-title":"Toxicol Lett"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/jid.2010.230","article-title":"FcgammaRIIA and FcgammaRIIIB Are required for autoantibody-induced tissue damage in experimental human models of bullous pemphigoid","volume":"130","author":"Yu","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/jid.2015.51","article-title":"Autoantibodies to multiple epitopes on the non-collagenous-1 domain of type VII collagen induce blisters","volume":"135","author":"Vorobyev","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1189\/jlb.72.1.183","article-title":"Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine","volume":"72","author":"Ludwig","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/jid.2014.453","article-title":"Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita","volume":"135","author":"Hirose","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1073\/pnas.0510756103","article-title":"Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases","volume":"103","author":"Nishimura","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/jid.2013.91","article-title":"Methylprednisolone blocks autoantibody-induced tissue damage through inhibition of neutrophil activation","volume":"133","author":"Hellberg","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14728222.2016.1148686","article-title":"Discovering potential drug-targets for personalized treatment of autoimmune disorders \u2013 what we learn from epidermolysis bullosa acquisita","volume":"19","author":"Witte","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/exd.13434","article-title":"CD11b-deficient mice exhibit an increased severity in the late phase of antibody transfer-induced experimental epidermolysis bullosa acquisita","volume":"26","author":"Deng","year":"2017","journal-title":"Exp Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.celrep.2016.09.006","article-title":"Non-canonical PI3K-Cdc42-Pak-Mek-Erk signaling promotes immune-complex-induced apoptosis in human neutrophils","volume":"17","author":"Chu","year":"2016","journal-title":"Cell Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.4049\/jimmunol.1002268","article-title":"Class IA phosphoinositide 3-kinase beta and delta regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae","volume":"186","author":"Boyle","year":"2011","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00228-017-2205-7","article-title":"First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3K\u03b4 inhibitor for the treatment of immune and inflammatory diseases","volume":"73","author":"Helmer","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1242\/jcs.020412","article-title":"PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP","volume":"121","author":"Heit","year":"2008","journal-title":"J Cell Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e83631","DOI":"10.1371\/journal.pone.0083631","article-title":"Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita","volume":"8","author":"Tiburzy","year":"2013","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T04:15:44Z","timestamp":1531368944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2018.01558"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01558","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]},"article-number":"1558"}}